Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

There will be scheduled maintenance work beginning on Saturday 15th June 2019 at 8:30 am through to Sunday 16th June 2019 at 11:30 pm (BST).

During this time our website may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 8, 2014
Previous Article Next Article

Quantification by SIFT-MS of volatile compounds emitted by in vitro cultures of S. aureus, S. pneumoniae and H. influenzae isolated from patients with respiratory diseases

Author affiliations

Abstract

In the light of the exciting recent developments in the detection of Pseudomonas aeruginosa in the breath of cystic fibrosis patients by measuring exhaled HCN, an in vitro study has been conducted to identify and quantify the volatile compounds emitted into the gas phase by other respiratory pathogens. Selected ion flow tube mass spectrometry (SIFT-MS) was used to investigate clinical isolates of Staphylococcus aureus (SA), Streptococcus pneumoniae (SP), and Haemophilus influenzae (HI). Six volatile compounds, mainly alcohols, ketones and aldehydes, were found to be elevated in the headspace of SA cultures and eight were elevated in the SP cultures. It is clear from the mass spectra that a number of other compounds were present at low levels that, as yet, cannot be identified by SIFT-MS alone. Only indole and ethanol were somewhat elevated in the headspace of some of the HI cultures. Principal component analyses (PCA) indicated that the SA cultures clearly separated into two distinct groups in terms of their volatile compound emissions. This may relate to genetic or phenotypic differences. It is postulated that the very efficient production of ethanol and acetaldehyde by SA and SP may provide indicators of airways infection by these bacteria if the levels of these compounds are elevated in exhaled breath above those levels expected due to their normal endogenously produced levels. Plans are in place to check this postulate by breath analysis studies involving patients with pulmonary infections with these organisms.

Graphical abstract: Quantification by SIFT-MS of volatile compounds emitted by in vitro cultures of S. aureus, S. pneumoniae and H. influenzae isolated from patients with respiratory diseases

Back to tab navigation

Publication details

The article was received on 23 Jan 2014, accepted on 01 Mar 2014 and first published on 13 Mar 2014


Article type: Paper
DOI: 10.1039/C4AY00209A
Anal. Methods, 2014,6, 2460-2472

  •   Request permissions

    Quantification by SIFT-MS of volatile compounds emitted by in vitro cultures of S. aureus, S. pneumoniae and H. influenzae isolated from patients with respiratory diseases

    T. W. E. Chippendale, F. J. Gilchrist, P. Španěl, A. Alcock, W. Lenney and D. Smith, Anal. Methods, 2014, 6, 2460
    DOI: 10.1039/C4AY00209A

Search articles by author

Spotlight

Advertisements